Lim Dae-Seog, Ko Si-Hwan, Kim Seung-Jin, Park Young-Jae, Park Jeon-Han, Lee Won-Young
Department of Microbiology, College of Medicine, Yonsei University, CPO Box 8044, Seoul 120-752, South Korea.
J Photochem Photobiol B. 2002 Jul;67(3):149-56. doi: 10.1016/s1011-1344(02)00318-4.
The efficacy of chlorophyll derivatives from silkworm excreta (CpD) in photodynamic antimicrobial chemotherapy (PACT) was studied. An enveloped animal virus, vesicular stomatitis virus (VSV), was used as a target organism. For CpD mediated PACT, the viruses in suspensions were treated with various doses of CpD (15-60 microg/ml) and visible red light was fixed at 120 mJ/cm(2). The antiviral effect of the CpD-PACT was measured 1 h after light irradiation by the extent of suppression of plaque forming units (pfu). In cultures inoculated with PACT-treated VSV, suppression of pfu was prominent and the results were demonstrated in a dose-dependent manner. In assays of RT-PCR, a single dose of 30 microg/ml CpD and light caused complete inhibition of viral RNA synthesis in the host cells, which agreed with the complete loss of plaque forming activity observed in pfu assays. An in vitro transcription assay for viral RNA using [3H]UTP and gel electrophoresis for the level of M protein was conducted. A gradual decrease in viral RNA transcription and an immediate decrease in M protein levels were observed in cells inoculated with the CpD-PACT-treated virus. These results demonstrated that CpD is a potential photodynamic antiviral agent, which causes inactivation of the matrix protein as well as transcription mechanisms involved in VSV replication.
研究了蚕沙叶绿素衍生物(CpD)在光动力抗菌化疗(PACT)中的疗效。一种包膜动物病毒,水疱性口炎病毒(VSV),被用作靶标生物。对于CpD介导的PACT,将悬浮液中的病毒用不同剂量的CpD(15 - 60微克/毫升)处理,并将可见红光固定在120毫焦/平方厘米。光照1小时后,通过噬斑形成单位(pfu)的抑制程度来测量CpD - PACT的抗病毒效果。在用PACT处理的VSV接种的培养物中,pfu的抑制作用显著,结果呈剂量依赖性。在逆转录聚合酶链反应(RT - PCR)测定中,单剂量30微克/毫升的CpD和光照导致宿主细胞中病毒RNA合成完全抑制,这与在pfu测定中观察到的噬斑形成活性完全丧失一致。使用[3H]UTP进行了病毒RNA的体外转录测定,并对M蛋白水平进行了凝胶电泳。在用CpD - PACT处理的病毒接种的细胞中,观察到病毒RNA转录逐渐减少,M蛋白水平立即下降。这些结果表明,CpD是一种潜在的光动力抗病毒剂,它会导致基质蛋白失活以及VSV复制中涉及的转录机制失活。